Actinium Pharmaceuticals (ATNM) Operating Leases (2019 - 2026)
Actinium Pharmaceuticals (ATNM) reported Operating Leases of $595,000 for Q2 2026, down 13.1% from $685,000 a year earlier and down 24.2% from the prior quarter.
Powered by 
Analysis
Actinium Pharmaceuticals (ATNM) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Actinium Pharmaceuticals posted Operating Leases of $972,000, down 1.2% from FY2024.
- Operating Leases has declined for three consecutive years, though with a five-year compound annual growth rate of 31.7% (FY2020 to FY2025).
- By year, Operating Leases came in at $984,000 in FY2024 (-36.6%), $1.55 million in FY2023 (-25.4%) and $2.08 million in FY2022.
- Five-year quarterly Operating Leases spans a low of $531,000 in Q3 2025 and a high of $2.21 million in Q3 2022.
- Year over year, Operating Leases has now declined in each of the last 12 quarters, with an average decline of 28.8% over the last eight quarters.
- Across the past five years, year-over-year decline in Operating Leases ran from 1.2% in Q4 2025 to 53.4% in Q3 2025.
- Per Business Quant data, the three quarters before Q2 2026 came in at $785,000 (Q1 2026), $972,000 (Q4 2025) and $531,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Actinium Pharmaceuticals | 37.10 Mn | 37.10 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 595,000.00 |
| Mar 31, 2026 | 785,000.00 |
| Dec 31, 2025 | 972,000.00 |
| Sep 30, 2025 | 531,000.00 |
| Jun 30, 2025 | 685,000.00 |
| Mar 31, 2025 | 836,000.00 |
| Dec 31, 2024 | 984,000.00 |
| Sep 30, 2024 | 1.14 Mn |
| Jun 30, 2024 | 1.28 Mn |
| Mar 31, 2024 | 1.41 Mn |
| Dec 31, 2023 | 1.55 Mn |
| Sep 30, 2023 | 1.69 Mn |
| Jun 30, 2023 | 1.82 Mn |
| Mar 31, 2023 | 1.95 Mn |
| Dec 31, 2022 | 2.08 Mn |
| Sep 30, 2022 | 2.21 Mn |
| Jun 30, 2021 | 62,000.00 |
| Mar 31, 2021 | 154,000.00 |
| Dec 31, 2020 | 245,000.00 |
| Sep 30, 2020 | 333,000.00 |
API Access
Actinium Pharmaceuticals Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=ATNM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "ATNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=ATNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();